Developmental immunotoxicity of dexamethasone: Comparison of fetal versus adult exposures

Toxicology

Volumn 194, Issue 1-2, 2003, Pages 163-176

  Dietert, Rodney R ^a   Lee, Ji Eun ^a,b   Olsen, John ^a   Fitch, Kevin ^a   Marsh, James A ^a  

^a Department of Obstetrics Gynecology   (United States)

^b CHEVRON PHILLIPS CHEMICAL COMPANY LP   (United States)

Author keywords

Developmental immunotoxicology; Dexamethasone; Immune assessment; In utero exposure; Rats

Indexed keywords

CELL SURFACE MARKER; DEXAMETHASONE SODIUM PHOSPHATE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; KEYHOLE LIMPET HEMOCYANIN; NITRIC OXIDE; TUMOR NECROSIS FACTOR;

ADULT; ADULTHOOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG EXPOSURE; FEMALE; FETUS; FLOW CYTOMETRY; HYPERSENSITIVITY REACTION; IMMUNOTOXICITY; JUVENILE; MACROPHAGE; MEDULLA OBLONGATA; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; RAT; REPRODUCTION; SPLEEN CELL; STATISTICAL SIGNIFICANCE; THYMUS;

EID: 0242661674     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2003.07.001     Document Type: Article

References (45)

1. Ahlbom E., Godvadze V., Chen M., Celsi G., Ceccatelli S. Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death. Proc. Natl. Acad. Sci. USA. 97(26):2000;14726-14730.
2. Ando T., Suganuma N., Furuhashi M., Asada Y., Kodo I., Tomoda Y. Successful glucocorticoid treatment for patients with abnormal autoimmunity on in vitro fertilization and embryo transfer. J. Assist. Reprod. Genet. 13:1996;776-781.
3. Ashwell J.D., Lu F.W.M., Vacchio M.S. Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 18:2000;309-345.
4. Bakker J.M., Kavelaars A., Kamphuis P.J.G.H., Cobelens P.M., Van Vugt H.H., van Bel F., Heijnen C.J. Neonatal dexamethasone treatment increases susceptibility to experimental autoimmune disease in adult rats. J. Immunol. 165:2000;5932-5937.
5. Bakker J.M., Schmidt E.D., Kroes H., Kavelaars A., Heijnen C.J., Tilders F.J., Rees E.P. Effects of short-term dexamethasone treatment during pregnancy on the development of the immune system and the hypothalamo-pituitary axis in the rat. J. Neuroimmunol. 63:1995;183-191.
6. Barnett J.B., Soderberg L.S.F., Menna J.H. The effect of chlordane on the delayed hypersensitivity response of BALB/c mice. Toxicol. Lett. 25:1987;173-183.
7. Bunn T.L., Ladics G.S., Holsapple M.P., Dietert R.R. Developmental immunotoxicity assessment in the rat: age, gender and strain comparisons after exposure to Pb. Toxicol. Methods. 11:2001a;41-58.
8. Bunn T.L., Parsons P.J., Kao E., Dietert R.R. Exposure to lead during critical windows of embryonic development: differential immunotoxic outcome based on stage of exposure and gender. Toxicol. Sci. 64:2001b;57-66.
9. Celsi G., Kistner A., Aizman R., Eklof A.C., Ceccatelli S., de Santiago A., Jacobson S.H. Prenatal dexamethasone causes oligonephronia, sodium retention and higher blood pressure in the offspring. Pediatr. Res. 44:1998;317-322.
10. Chapin R.E., Harris M.W., Davis B.J., Ward S.M., Wilson R.E., Mauney M.A., Lockhart A.C., Smialowicz R.J., Moser V.C., Burka L.T., Collins B.J. The effects of perinatal/juvenile methoxychlor exposure on adult immune and reproductive system function. Fundam. Appl. Toxicol. 40:1997;138-157.
11. Chen S.S., Golemboski K.A., Sanders F.S., Dietert R.R. Persistent effect of in utero meso-2,3-dimercaptosuccinic acid (DMSA) on immune function and lead-induced immunotoxicity. Toxicology. 132:1999;67-79.
12. Coe C.L., Lubach G.R., Karaszewski J.W. Prenatal stress and immune recognition of self and nonself in the primate neonate. Biol. Neonate. 76:1999;301-310.
13. Crane J., Armsons A., Brunner M., de La Ronde S., Farine D., Keenan-Lindsay L., Leduc L., Schneider C., Van Aerde J. Antenatal corticosteroid therapy for fetal maturation. J. Obstet. Gynaecol. Can. 25:2003;45-52.
14. Daynes R.A., Araneo B.A. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interluekin 2 and interleukin 4. Eur. J. Immunol. 19:1989;2319-2325.
15. Dietert R.R., Lee J.-E., Bunn T.L. Developmental immunotoxicology: emerging issues. Hum. Exp. Toxicol. 21:2002;479-485.
16. Dietert R.R., Qureshi M.A., Nanna U.C., Bloom S.E. Embryonic exposure to Aflatoxin-B1: mutagenicity and influence on development and immunity. Environ. Mutagen. 7:1985;715-725.
17. Exon J.H., Bussiere J.L., Mather G.C. Immunotoxicity testing in the rat: an improved multiple assay model. Int. J. Immunopharmacol. 12:1990;699-701.
18. Exon J.H., Talcott P.A. Enzyme-linked immunosorbant assay (ELISA) for detection of specific IgG antibody in the rat. Method. Immunol. 1:1995;109-124.
19. Faith R.E., Luster M.I., Kimmel C.A. Effects of combined pre- and postnatal lead exposure on cell mediated immune functions. Clin. Exp. Immunol. 35:1979;413-420.
20. Fine J.S., Gasiewicz T.A., Silverstone A.E. Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol. Pharmacol. 35:1989;18-25.
21. Gehrs B.C., Smialowicz R.J. Persistent suppression of the delayed type hypersensitivity response in adult F344 rats after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. 134:1999;79-88.
22. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tanneubaum S.R. Analysis of nitrate, nitrite and [15]N nitrite in biological fluids. Anal. Biochem. 126:1982;131-138.
23. Ghosh B., Wood C.R., Held G.A., Abbott B.D., Lau C. Glucocorticoid receptor regulation in the rat embryo: a potential site for developmental toxicity? Toxicol. Appl. Pharmacol. 164:2000;221-229.
24. Holladay S.D., Smith B.J. Benzo[a]pyrene-induced alterations in total immune cell number and cell-surface antigen expression in the thymus, spleen and bone marrow of B6C3F1 mice. Vet. Hum. Toxicol. 37:1995;99-104.
25. Holladay S.D., Blaylock B.L., Comment C.E., Heindel J.J., Luster M.I. Fetal thymic atrophy after exposure to T2 toxin: selectivity for lymphoid progenitor cells. Toxicol. Appl. Pharmacol. 121:1993;8-14.
26. Holsapple M.P. Developmental immunotoxicology and risk assessment: a workshop summary. Hum Exp. Toxicol. 21:2002;473-478.
27. Kavelaars A., Zijlstra J., Bakker J.M., Van Rees E.P., Visser G.H.A., Zegers B.J.M., Heijnen C.J. Increased dexamethasone sensitivity of neonatal leukocytes: differential mecahnisms of glucocorticoid inhibition of T cell proliferation in adult and neonatal cells. Eur. J. Immunol. 25:1995;1346-1351.
28. LaBorde J.B., Hansen D.K., Young J.F., Sheehan D.M., Holson R.R. Prenatal dexamethasone exposure in rats: effects of dose, age of exposure, ands drug-induced hypophagia on malformations and organ weights. Fund. Appl. Toxicol. 19:1992;545-554.
29. Luster M.I., Faith R.E., McLachlan J.A., Clark G.C. Effect of in utero exposure to diethylstillbesterol on the immune response of mice. Toxicol. Appl. Pharmacol. 47:1979;287-296.
30. Luster M.I., Dean J.H., Germolec D.R. Consensus workshop on methods to evaluate developmental immunoxicity. Env. Health Perspect. 111:2003;579-583.
31. Miller T., Golemboski K.A., Ha R.A., Bunn T., Sanders F.S., Dietert R.R. Developmental exposure to Pb causes persistent immunotoxicity in Fisher 344 rats. Toxicol. Sci. 42:1998;129-135.
32. Muneoka K., Mikuni M., Ogawa T., Kitera K., kamei K., Takigawa M., Takahashi K. Prenatal dexamethasone exposure alters brain monoamine metabolism and adrenocortical response in rat offspring. Amer. J. Physiol. 273:1997;R1669-R1675.
33. Nelson-Ortiz D.L., Oureshi M.A. Effects of AFB1 embryonic exposure on chicken mononuclear phagocytic cell functions. Devel. Comp. Immunol. 16:1992;187-196.
34. Nyrienda M.J., Welberg I.A.M., Seckl J.R. Programming hyperglycaemia in the rat through prenatal exposure to glucocorticoids-fetal effect or maternal influence? J. Endocrin. 170:2001;653-660.
35. Peden D.B. Development of atopy and asthma: candidate environmental influences and important periods of exposure. Env. Health Perspect. 108(Suppl. 2):2000;475-482.
36. Ramirez F., Fowell D.J., Puklavec M., Simmons S., Mason D. Glucocorticoids promote a Th2 cytokine response by CD4+ T cell in vitro. J. Immunol. 156:1996;2406-2412.
37. Seckl J.R. Physiologic programming of the fetus. Clin. Perinatal. 25:1998;939-962.
38. Segren C.M., Sonneveld P., van der Holt B., Baars J.W., Biesma D.H., Cornellissen J.J., Croockewit A.J., Dekker A.W., Fibbe W.E., Lowenberg B., van Markwijk Kooy M., van Oers M.H.J., Richel D.J., Schouten H.C., Vellenga E., Verhoef G.E.C., Wijermans P.W., Wittebol S., Lokhorst H.M. Vincristine, doxorubicin and dexamethasone (VAD) administration as rapid intravenous infusion for first-line treatment in untreated multiple myeloma. Brit. J. Haematol. 105:1999;127-130.
39. Smialowicz R.J., Riddle M.M., Rogers R.R., Luebke R.W., Copeland C.B. Immunotoxicity of tributyltin oxide in rats exposed as adults or pre-weanlings. Toxicol. 57:1989;97-111.
40. Smialowicz R.J., Williams W.C., Copeland C.B., Harris M.W., Overstree D., Davis B.J., Chapin R.E. Effect of perinatal/juvenile heptachlor exposure on the adult immune and reproductive function in rats. Toxicol. Sci. 61:2001;164-175.
41. Tsukahara H., Watanabe Y., Yautomi M., kobata R., Tamura S., Kimura K., Hiraoka M., Mayumi M. Early (4-7 days of age) dexamethasone therapy for prevention of chronic lung disease in preterm infants. Biol. Neonate. 76:1999;289-290.
42. Ways S.C., Blair P.B., Bern H.A., Staskawicz M.O. Immune responsiveness of adult mice exposed neonatally to DES, steroid hormones, or vitamin A. J. Environ. Pathol. Toxicol. 3:1980;207-216.
43. Wenting-van Wijk M.J., Blaakenstein M.A., Lafeber F.P., Bijlsma J.W. Relation of plasma dexamethasone to clinical response. Clin. Exp. Rheumatol. 17:1999;305-312.
44. Wu C.Y., Faregas C., Nakajima T., Delespesse G. Glucocorticoids suppress the production of IL-4 by human lymphocytes. Eur. J. Immunol. 21:1991;2645-2647.
45. Ziaei S., Rosenbehani N., Kazeminejad A., Zafarghandi S. The effects of intramuscular administration of corticosteroids on the induction of parturition. J. Perinat. Med. 31:2003;134-139.